Filing Details
- Accession Number:
- 0001209191-21-009472
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-10 20:31:50
- Reporting Period:
- 2021-02-08
- Accepted Time:
- 2021-02-10 20:31:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1180262 | Herbalife Nutrition Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1463405 | John Desimone | 800 W. Olympic Boulevard, #406 Los Angeles CA 90015 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-08 | 38,018 | $0.00 | 64,844 | No | 4 | A | Direct | |
Common Stock | Disposition | 2021-02-08 | 16,226 | $55.83 | 48,618 | No | 4 | F | Direct | |
Common Stock | Disposition | 2021-02-08 | 7,569 | $56.00 | 138,401 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2021-02-09 | 65,416 | $56.00 | 72,985 | No | 4 | S | Indirect | By Trust |
Common Stock | Disposition | 2021-02-10 | 6,180 | $59.00 | 66,805 | No | 4 | S | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
Footnotes
- Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period.
- Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Trust.
- This transaction was executed in multiple trades at prices ranging from $56.00 to $56.005. The price reported reflects the weighted average sale price of $56.0006. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.